399 related articles for article (PubMed ID: 18636159)
21. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.
Yu S; Wang X; Ng CF; Chen S; Chan FL
Cancer Res; 2007 May; 67(10):4904-14. PubMed ID: 17510420
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells.
Boyanapalli SS; Li W; Fuentes F; Guo Y; Ramirez CN; Gonzalez XP; Pung D; Kong AN
Pharmacol Res; 2016 Dec; 114():175-184. PubMed ID: 27818231
[TBL] [Abstract][Full Text] [Related]
23. Defects in p21WAF1/CIP1, Rb, and c-myc signaling in phorbol ester-resistant cancer cells.
Blagosklonny MV; Prabhu NS; El-Deiry WS
Cancer Res; 1997 Jan; 57(2):320-5. PubMed ID: 9000576
[TBL] [Abstract][Full Text] [Related]
24. Repression of androgen receptor in prostate cancer cells by phenethyl isothiocyanate.
Wang LG; Liu XM; Chiao JW
Carcinogenesis; 2006 Oct; 27(10):2124-32. PubMed ID: 16704988
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory role of TGIF in the As2O3-regulated p21 WAF1/CIP1 expression.
Liu ZM; Huang HS
J Biomed Sci; 2008 May; 15(3):333-42. PubMed ID: 18210215
[TBL] [Abstract][Full Text] [Related]
26. Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo.
Xiao D; Singh SV
Cancer Res; 2007 Mar; 67(5):2239-46. PubMed ID: 17332354
[TBL] [Abstract][Full Text] [Related]
27. AP4 encodes a c-MYC-inducible repressor of p21.
Jung P; Menssen A; Mayr D; Hermeking H
Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15046-51. PubMed ID: 18818310
[TBL] [Abstract][Full Text] [Related]
28. Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells.
Roy S; Packman K; Jeffrey R; Tenniswood M
Cell Death Differ; 2005 May; 12(5):482-91. PubMed ID: 15746940
[TBL] [Abstract][Full Text] [Related]
29. Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity.
Ouchi H; Ishiguro H; Ikeda N; Hori M; Kubota Y; Uemura H
Int J Urol; 2005 Jan; 12(1):73-80. PubMed ID: 15661057
[TBL] [Abstract][Full Text] [Related]
30. The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells.
Archer SY; Johnson J; Kim HJ; Ma Q; Mou H; Daesety V; Meng S; Hodin RA
Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G696-703. PubMed ID: 16160080
[TBL] [Abstract][Full Text] [Related]
31. Phenethyl isothiocyanate-induced apoptosis in PC-3 human prostate cancer cells is mediated by reactive oxygen species-dependent disruption of the mitochondrial membrane potential.
Xiao D; Lew KL; Zeng Y; Xiao H; Marynowski SW; Dhir R; Singh SV
Carcinogenesis; 2006 Nov; 27(11):2223-34. PubMed ID: 16774948
[TBL] [Abstract][Full Text] [Related]
32. Recruitment of HDAC4 by transcription factor YY1 represses HOXB13 to affect cell growth in AR-negative prostate cancers.
Ren G; Zhang G; Dong Z; Liu Z; Li L; Feng Y; Su D; Zhang Y; Huang B; Lu J
Int J Biochem Cell Biol; 2009 May; 41(5):1094-101. PubMed ID: 19013255
[TBL] [Abstract][Full Text] [Related]
33. p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest.
Ho JS; Ma W; Mao DY; Benchimol S
Mol Cell Biol; 2005 Sep; 25(17):7423-31. PubMed ID: 16107691
[TBL] [Abstract][Full Text] [Related]
34. The plant alkaloid cryptolepine induces p21WAF1/CIP1 and cell cycle arrest in a human osteosarcoma cell line.
Matsui TA; Sowa Y; Murata H; Takagi K; Nakanishi R; Aoki S; Yoshikawa M; Kobayashi M; Sakabe T; Kubo T; Sakai T
Int J Oncol; 2007 Oct; 31(4):915-22. PubMed ID: 17786325
[TBL] [Abstract][Full Text] [Related]
35. DNA topoisomerase II inhibitor, etoposide, induces p21WAF1/CIP1 through down-regulation of c-Myc in K562 cells.
Horiguchi-Yamada J; Fukumi S; Saito S; Nakayama R; Iwase S; Yamada H
Anticancer Res; 2002; 22(6C):3827-32. PubMed ID: 12553001
[TBL] [Abstract][Full Text] [Related]
36. Histone acetylation is not an accurate predictor of gene expression following treatment with histone deacetylase inhibitors.
Ellis DJ; Lawman ZK; Bonham K
Biochem Biophys Res Commun; 2008 Mar; 367(3):656-62. PubMed ID: 18179771
[TBL] [Abstract][Full Text] [Related]
37. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
[TBL] [Abstract][Full Text] [Related]
38. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.
Lin YC; Lin JH; Chou CW; Chang YF; Yeh SH; Chen CC
Cancer Res; 2008 Apr; 68(7):2375-83. PubMed ID: 18381445
[TBL] [Abstract][Full Text] [Related]
39. Role of mitogen-activated protein kinases in phenethyl isothiocyanate-induced apoptosis in human prostate cancer cells.
Xiao D; Choi S; Lee YJ; Singh SV
Mol Carcinog; 2005 Jul; 43(3):130-40. PubMed ID: 15880419
[TBL] [Abstract][Full Text] [Related]
40. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter.
Wu S; Cetinkaya C; Munoz-Alonso MJ; von der Lehr N; Bahram F; Beuger V; Eilers M; Leon J; Larsson LG
Oncogene; 2003 Jan; 22(3):351-60. PubMed ID: 12545156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
